1st Quarter - Report
ARENTFOX SCHIFF LLP for TRANSPARENCY-RX CORP.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices H.R.7148 (Consolidated Appropriations Act, 2026), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| KELSEY GRISWOLD-BERGER | — |
| KATHERINE KRAMER | — |
| DANIEL SJOSTEDT | — |
| BLAKE THELANDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.